Resources
- HER2 Targeted Therapies In Breast Cancer
- Application of PEGs In The Field Of Medical Devices
- c-MET: A Novel Target for Anticancer Therapies
- Novel FRα-targeting Antibody-drug Conjugates (ADCs)
- FDA Approves Tivdak - First Tissue Factor (TF)-Targeted Antibody Conjugate Drug (ADC)
- Advantages and Disadvantages of PEGylated Liposomes in Drug Delivery System
- Anti-obesity Medications (AOMs): History And Progress
- Clinical Development of ADC Drugs Targeting TROP-2
- PROTACs VS. Traditional Small Molecule Inhibitors
- Summary of PROTAC Degraders in Clinical Trials
